ScreenerHero

XBIT XBiotech Inc.

NAS · US · Healthcare · Biotechnology · xbiotech.com
2.160USD-0.92%Mkt Cap: 65.85M $P/E: —

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious dise…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.24BUSDP/E 29.3
REGN
Regeneron Pharmaceuticals, Inc.
$76.05BUSDP/E 18.3
MRNA
Moderna, Inc.
$74.84BUSD
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.21BUSDP/E 35.5
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$42.84BUSD
ONC
BeOne Medicines AG
$41.27BUSDP/E 64.9
RPRX
Royalty Pharma plc
$32.61BUSDP/E 30.0
ALNY
Alnylam Pharmaceuticals, Inc.
$29.97BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.66BUSD
BNTX
BioNTech SE
$24.05BUSD
GMAB
Genmab A/S
$23.24BUSDP/E 29.8
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INSM
Insmed Incorporated
$22.98BUSD
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
JAZZ
Jazz Pharmaceuticals plc
$15.02BUSDP/E 15.9
ASND
Ascendis Pharma A/S
$14.87BUSDP/E 17.3
EXEL
Exelixis, Inc.
$14.45BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$13.81BUSD

Key Statistics

Company
Market Cap65.85M USD
Enterprise Value-43.67M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-45.54M USD
Revenue/Share—
Last Price2.160 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees87
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)16.62
PEG—
EV/EBITDA0.93
EV/Revenue—
P/S—
P/B0.51
EPS (TTM)-1.45
EPS (Forward)0.13
52W Range
2.0905% of range3.440
52W High3.440 USD
52W Low2.090 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-32.45%
ROA-30.34%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-39.92M USD
CapEx (TTM)289.00K USD
FCF Margin—
FCF Yield-43.27%
Net Debt-109.53M USD
Net Debt/EBITDA2.34
Balance Sheet
Debt/Equity—
Current Ratio33.15
Quick Ratio32.75
Book Value/Sh4.21 USD
Cash/Share3.59 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJul 15, 2021
Pay DateJul 23, 2021
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.30.49M
Float22.84M
Insiders36.87%
Institutions6.73%
Short Interest
Short Ratio7.0d
Short % Float1.33%
Short % Out.1.14%
Shares Short347.12K
Short (prev mo.)332.98K
Technical
SMA 502.238 (-3.5%)
SMA 2002.365 (-8.7%)
Beta0.80
S&P 52W Chg16.45%
Avg Vol (30d)44.22K
Avg Vol (10d)26.94K
Technical Indicators
RSI (14)40.3
MACD-0.0204
MACD Signal-0.0239
MACD Hist.+0.0035
BB Upper2.209 USD
BB Middle2.181 USD
BB Lower2.152 USD
BB Width2.60%
ATR (14)0.0395 USD
Vol Ratio (20d)0.26x